For: | Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, LeMarchand L, Lindor NM, Potter JD, Newcomb PA. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol 2013; 19(21): 3241-3248 [PMID: 23745025 DOI: 10.3748/wjg.v19.i21.3241] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i21/3241.htm |
Number | Citing Articles |
1 |
Rajeev K. Salunke, Murali Dharan, John W. Birk. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 265 doi: 10.1007/978-3-030-81780-0_11
|
2 |
Pierre Fwelo, Oladipo Afolayan, Kenechukwu O.S. Nwosu, Akpevwe A. Ojaruega, Onyekachi Ahaiwe, Olajumoke A. Olateju, Ogochukwu Juliet Ezeigwe, Toluwani E. Adekunle, Ayrton Bangolo. Racial and ethnic differences in colon cancer surgery type performed and delayed treatment among people 45 years old and older in the USA between 2007 and 2017: Mediating effect on survival. Surgical Oncology 2023; 50: 101983 doi: 10.1016/j.suronc.2023.101983
|
3 |
Azah A Althumairi, Mark G Lazarev, Susan L Gearhart. Inflammatory bowel disease associated neoplasia: A surgeon’s perspective. World Journal of Gastroenterology 2016; 22(3): 961-973 doi: 10.3748/wjg.v22.i3.961
|
4 |
Massimo Claudio Fantini, Ilaria Guadagni. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Digestive and Liver Disease 2021; 53(5): 558 doi: 10.1016/j.dld.2021.01.012
|
5 |
Christof Kaltenmeier, Chengli Shen, David S. Medich, David A. Geller, David L. Bartlett, Allan Tsung, Samer Tohme. Time to Surgery and Colon Cancer Survival in the United States. Annals of Surgery 2021; 274(6): 1025 doi: 10.1097/SLA.0000000000003745
|
6 |
Luca Roncucci, Francesco Mariani. Prevention of colorectal cancer: How many tools do we have in our basket?. European Journal of Internal Medicine 2015; 26(10): 752 doi: 10.1016/j.ejim.2015.08.019
|
7 |
|
8 |
Sabrina Jeppsson, Shanthi Srinivasan, Bindu Chandrasekharan. Neuropeptide Y (NPY) promotes inflammation-induced tumorigenesis by enhancing epithelial cell proliferation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(2): G103 doi: 10.1152/ajpgi.00410.2015
|
9 |
Alan Askari, Luis Sánchez Guillén, Monica Millan, Subramanian Nachiappan, Alex Bottle, Thanos Athanasiou, Omar Faiz. Colorectal tumour characteristics and oncological outcome in patients with inflammatory bowel disease. Surgical Practice 2020; 24(2): 60 doi: 10.1111/1744-1633.12421
|
10 |
Mark A. Jenkins, Aung K. Win, Noralane M. Lindor. Hereditary Colorectal Cancer. 2018; : 427 doi: 10.1007/978-3-319-74259-5_27
|
11 |
Christopher C. Taylor, Valentine O. Millien, Jason K. Hou, Nader N. Massarweh. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival. Journal of Surgical Research 2020; 247: 77 doi: 10.1016/j.jss.2019.10.040
|
12 |
Hadis Najafimehr, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Hamid Mohaghegh Shalmani, Amir Vahedian-Azimi, Matthew Kroh, Mohammad Reza Zali, Amirhossein Sahebkar, Muhammad Naeem. A Systematic Review and Meta-Analysis on the Association between Inflammatory Bowel Disease Family History and Colorectal Cancer. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/4874459
|
13 |
Carol J. Díaz-Díaz, Sean M. Ronnekleiv-Kelly, Manabu Nukaya, Peter G. Geiger, Silvia Balbo, Romel Dator, Bryant W. Megna, Patrick R. Carney, Christopher A. Bradfield, Gregory D. Kennedy. The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. Annals of Surgery 2016; 264(3): 429 doi: 10.1097/SLA.0000000000001874
|
14 |
Mitchell Ramsey, Somashekar G Krishna, Peter P Stanich, Syed Husain, Edward J Levine, Darwin Conwell, Alice Hinton, Cheng Zhang. Inflammatory Bowel Disease Adversely Impacts Colorectal Cancer Surgery Short-term Outcomes and Health-Care Resource Utilization. Clinical and Translational Gastroenterology 2017; 8(11): e127 doi: 10.1038/ctg.2017.54
|
15 |
László Herszényi, Loránd Barabás, Pál Miheller, Zsolt Tulassay. Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk. Digestive Diseases 2015; 33(1): 52 doi: 10.1159/000368447
|
16 |
Yifan Li, Huanyu Li, Manli Cui, Ying Zhou, Mingzhen Zhang, Mingxin Zhang. Interaction of Exosomal MicroRNA and Oxidative Stress in the Pathogenesis of Colitis-Associated Cancer. Frontiers in Bioscience-Landmark 2024; 29(8) doi: 10.31083/j.fbl2908276
|
17 |
Ramzi Amri, Liliana G. Bordeianou, Patricia Sylla, David L. Berger. Treatment Delay in Surgically-Treated Colon Cancer: Does It Affect Outcomes?. Annals of Surgical Oncology 2014; 21(12): 3909 doi: 10.1245/s10434-014-3800-9
|
18 |
Baochi Ou, Jingkun Zhao, Shaopei Guan, Aiguo Lu. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences 2016; 61(3): 881 doi: 10.1007/s10620-015-3940-1
|
19 |
Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, Doris Wagner, Kazunari Sasaki, Boris Galjart, Carsten Kamphues, Timothy M Pawlik, George Poultsides, Klaus Kaczirek, Per Eystein Lønning, Cornelis Verhoef, Martin E Kreis, Christopher L Wolfgang, Matthew J. Weiss. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis. Journal of Surgical Oncology 2018; 118(7): 1074 doi: 10.1002/jso.25251
|
20 |
Jingyue Zhang, Chaoyue Chen, Wei Yan, Yu Fu. New sights of immunometabolism and agent progress in colitis associated colorectal cancer. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1303913
|
21 |
Can Lu, Josefine Schardey, Tao Zhang, Alexander Crispin, Ulrich Wirth, Konrad W. Karcz, Alexandr V. Bazhin, Joachim Andrassy, Jens Werner, Florian Kühn. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer. Annals of Surgery 2022; 276(5): e319 doi: 10.1097/SLA.0000000000005339
|
22 |
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, Thorsten Maretzky, Prajwal Gurung, Nandakumar S. Narayanan, Sarah Short, Yiqin Xiong, Zizhen Kang. LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation. Cells 2024; 13(7): 565 doi: 10.3390/cells13070565
|